News LifeArc spends Keytruda cash on R&D ignored by pharma Formerly known as MRC Technology, charity to spend Keytruda royalties on R&D considered too risky by big pharma
News BenevolentAI to power small molecule drug discovery Deal with MRCT will look for potential new drug targets and candidates.
News AstraZeneca and MRC to create new centre for early drug disc... AstraZeneca and the UK's Medical Research Council have unveiled a groundbreaking collaboration which will see them working hand-in-hand in a joint research facility in Cambridge in the UK.<
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
